Validation of the "multivalvular score" for the assessment of patients with concomitant mitral and aortic valve disease under evaluation for transcatheter aortic valve implantation.

Back

ESC Premium Access

Validation of the "multivalvular score" for the assessment of patients with concomitant mitral and aortic valve disease under evaluation for transcatheter aortic valve implantation.

Session: Controversies and unmet needs around TAVI

Topic: Aortic Valve Intervention

Speaker: Doctor P. Catala-Ruiz (Barcelona, ES)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Pablo Catala-Ruiz

University Hospital Bellvitge, Barcelona (Spain)

0 follower

4 more presentations in this session

Survival and Long-term clinical outocmes after Transcatheter Aortic Valve Replacement in high-risk patients with severe aortic stenosis.

Speaker: Doctor A. Munoz Garcia (Malaga, ES)

Impact of primary hemostasis disorders on late (>30 days) major/life-threatening bleedings after TAVR

Speaker: Doctor M. Kibler (Strasbourg, FR)

Impact of coronary artery disease and PCI on Long-term outcomes of women undergoing transcatheter aortic valve replacement: insights from the multi-center WIN-TAVI registry

Speaker: Doctor P. Guedeney (Paris, FR)

Impact of prosthetic valve regurgitation quantified by cardiac magnetic resonance imaging on long-term mortality after TAVI

Speaker: Doctor M. Abdelghani (Cairo, EG)

Access the full session

Controversies and unmet needs around TAVI

Speakers: Doctor P. Catala-Ruiz, Doctor A. Munoz Garcia, Doctor M. Kibler, Doctor P. Guedeney, Doctor M. Abdelghani

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources